| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adenosine acts as an inhibitor of lymphoma cell growth
|
Fishman, P.
|
|
2000
|
36 |
11 |
p. 1452-1458
7 p.
|
artikel
|
| 2 |
Comments on: Applicability of the Health Utilities Index to a population of childhood survivors of central nervous system tumours in the UK Glaser AW, Furlong W, Waltzer DA, et al. Eur J Cancer 1999, 35, 256–261
|
Dlugos, D
|
|
2000
|
36 |
11 |
p. 1459-1460
2 p.
|
artikel
|
| 3 |
DNA adduct level in lung tissue may act as a risk biomarker of lung cancer
|
Cheng, Y.-W
|
|
2000
|
36 |
11 |
p. 1381-1388
8 p.
|
artikel
|
| 4 |
Identification of risk groups in hepatoblastoma — another step in optimising therapy
|
von Schweinitz, D
|
|
2000
|
36 |
11 |
p. 1343-1346
4 p.
|
artikel
|
| 5 |
Initiation-development modelling of allelic losses on chromosome 9 in multifocal bladder cancer
|
Louhelainen, J
|
|
2000
|
36 |
11 |
p. 1441-1451
11 p.
|
artikel
|
| 6 |
Macromolecule uptake in human melanoma xenografts
|
Graff, B.A
|
|
2000
|
36 |
11 |
p. 1433-1440
8 p.
|
artikel
|
| 7 |
Paclitaxel exposure time determines the nature of the interaction with radiation in HeLa cells
|
Yildiz, F.
|
|
2000
|
36 |
11 |
p. 1426-1432
7 p.
|
artikel
|
| 8 |
Pretreatment prognostic factors for children with hepatoblastoma — results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1
|
Brown, J.
|
|
2000
|
36 |
11 |
p. 1418-1425
8 p.
|
artikel
|
| 9 |
Prevalence of complementary therapy use by women with breast cancer
|
Rees, R.W
|
|
2000
|
36 |
11 |
p. 1359-1364
6 p.
|
artikel
|
| 10 |
Prognosis and clinical presentation of BRCA2-associated breast cancer
|
Loman, N
|
|
2000
|
36 |
11 |
p. 1365-1373
9 p.
|
artikel
|
| 11 |
Prostate cancer screening: the problem of overdiagnosis and lessons to be learned from breast cancer screening
|
Ciatto, S
|
|
2000
|
36 |
11 |
p. 1347-1350
4 p.
|
artikel
|
| 12 |
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group
|
Hakamies-Blomqvist, L
|
|
2000
|
36 |
11 |
p. 1411-1417
7 p.
|
artikel
|
| 13 |
Response from D. Feeny, et al.
|
Feeny, D.
|
|
2000
|
36 |
11 |
p. 1460-1461
2 p.
|
artikel
|
| 14 |
The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients
|
André, F
|
|
2000
|
36 |
11 |
p. 1389-1394
6 p.
|
artikel
|
| 15 |
The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia
|
Perego, R.A
|
|
2000
|
36 |
11 |
p. 1395-1401
7 p.
|
artikel
|
| 16 |
The role of cathepsin D and PAI-1 in primary invasive breast cancer as prognosticators and predictors of treatment benefit with adjuvant tamoxifen
|
Billgren, A.-M
|
|
2000
|
36 |
11 |
p. 1374-1380
7 p.
|
artikel
|
| 17 |
The role of meta-analyses in assessing cancer treatments
|
Sylvester, R
|
|
2000
|
36 |
11 |
p. 1351-1358
8 p.
|
artikel
|
| 18 |
Variants of the long control region of human papillomavirus type 16
|
Kurvinen, K.
|
|
2000
|
36 |
11 |
p. 1402-1410
9 p.
|
artikel
|
Tijdschrift beschrijving